Yes, chemotherapy is immunosuppressive. It is one of the most significant causes of immune suppression in cancer treatment, and the effect can last months or even longer after treatment ends. Chemotherapy drugs work by killing rapidly dividing cells, but they cannot distinguish between cancer cells and the healthy cells in your bone marrow that produce your immune system’s white blood cells. The result is a measurable, sometimes dangerous drop in your body’s ability to fight infection.
How Chemotherapy Suppresses the Immune System
Your bone marrow constantly produces the white blood cells that form the backbone of your immune defenses. Bone marrow cells divide rapidly, which makes them especially vulnerable to chemotherapy drugs designed to target fast-growing cells. When chemotherapy damages these precursor cells, the supply of new white blood cells drops, a condition called myelosuppression.
This triggers a cascade of problems. Your neutrophil count falls (neutropenia), reducing your first line of defense against bacteria and fungi. Your lymphocyte count falls (lymphopenia), weakening the part of your immune system responsible for fighting viruses and recognizing abnormal cells. Platelet and red blood cell production also take a hit, raising the risk of bleeding and anemia. In studies of patients with breast cancer, colon cancer, leukemia, lymphoma, and sarcoma, white blood cell counts consistently decreased after chemotherapy across all cancer types.
Which Immune Cells Are Hit Hardest
Lymphocytes are specifically sensitive to chemotherapy and often decrease more than other cell types. Their depletion weakens your adaptive immune system, the branch that remembers past infections and coordinates targeted attacks against specific threats. This increases vulnerability to viral infections and reduces the body’s ongoing surveillance against new cancers.
Neutrophils, the immune cells that respond first to bacterial invaders, are also heavily affected. In one retrospective study of cancer patients, the rate of neutropenia rose from about 22% before chemotherapy to 28% afterward. The real-world impact is even more striking: in a study of 92 patients receiving chemotherapy for solid tumors, roughly 71% developed neutropenia over the course of treatment, and half developed febrile neutropenia, meaning their neutrophil counts dropped low enough that they developed a fever signaling possible infection.
The Nadir: When You’re Most Vulnerable
After each chemotherapy cycle, your blood counts don’t drop instantly. They decline gradually, reaching their lowest point at a period called the nadir. For most chemotherapy regimens, the neutrophil nadir occurs around 10 to 17 days after treatment. During this window, your infection risk peaks.
Neutropenia is classified by severity based on your absolute neutrophil count (ANC). Mild neutropenia is an ANC between 1,000 and 1,500 cells per microliter. Moderate neutropenia falls between 500 and 1,000. Severe neutropenia, where infection risk is highest, means an ANC below 500. For context, a healthy ANC typically ranges from 2,500 to 7,000.
If your temperature reaches 101°F (38.3°C) or stays at 100.4°F (38°C) for an hour or more while your ANC is below 1,500, that qualifies as febrile neutropenia. This is treated as a medical emergency because your body may lack the immune cells needed to contain even a minor infection.
How Long Immune Suppression Lasts
One of the most important things to understand is that immune suppression does not end when chemotherapy ends. Recovery is slow and highly variable. A study tracking breast cancer patients after adjuvant therapy found that significant immune impairment persisted at 12 months post-treatment across numerous immune measures. At that point, depending on the specific immune function being measured, only 6% to 76% of patients had recovered to their pre-treatment baseline.
Some aspects of immunity recover faster than others. Basic cell counts may rebound within weeks to months, but functional immune responses, like your lymphocytes’ ability to multiply in response to a threat, can remain suppressed much longer. In that same study, the probability of recovering certain key immune signaling responses was only about 19% at the 12-month mark, actually lower than at earlier time points. This suggests that for some patients, certain immune functions continue to decline even after treatment stops before they eventually begin to rebuild.
Practical Precautions During Treatment
Because your immune defenses are compromised, everyday situations carry more risk during and after chemotherapy. The National Cancer Institute recommends several precautions:
- Hand hygiene: Wash your hands frequently with soap and warm water, especially before eating. Ask the people around you to do the same.
- Avoiding exposure: Stay away from people who are sick, avoid crowds when possible, and keep distance from anyone who recently received a live vaccine (such as chickenpox or measles).
- Food safety: Cook meat, fish, and eggs thoroughly. Keep hot foods hot and cold foods cold. Stick to fruits and vegetables that can be peeled, or wash raw produce very well.
- Skin and mouth care: Clean any cuts or scrapes promptly. Check your mouth daily for sores. If you have a catheter, keep the area clean and dry.
Vaccines and Chemotherapy
Chemotherapy changes the rules around vaccination. The CDC considers anyone receiving chemotherapy to have altered immunocompetence, which affects both the safety and effectiveness of vaccines.
Live vaccines, which contain weakened but active viruses or bacteria, should not be given during chemotherapy. Without a functioning immune system to keep them in check, even attenuated vaccine organisms could cause the disease they’re meant to prevent. Live vaccines need to be withheld for at least three months after immunosuppressive therapy ends.
Non-live vaccines (like flu shots) are generally safe during treatment, but they may not work well because your immune system can’t mount a strong enough response to build protection. The CDC recommends that any non-live vaccine given during chemotherapy be repeated after immune function recovers. Vaccines given within 14 days before starting chemotherapy should also be considered ineffective and repeated at least three months after treatment ends, assuming your immune system has recovered.
When possible, the best approach is to get all recommended vaccines before chemotherapy begins, ideally at least two weeks before the first cycle. This gives your immune system time to respond while it’s still functioning at full capacity.
Why This Matters Beyond Infection
The immune suppression from chemotherapy has implications beyond catching a cold or developing a fever. Lymphocytes play a role in immune surveillance, your body’s ongoing process of identifying and destroying abnormal cells before they become problematic. When lymphocyte counts and function are impaired for months after treatment, this surveillance system operates at reduced capacity. This is one reason oncologists carefully monitor blood work long after the last chemotherapy session, and why recovery of immune function is a meaningful milestone in the months following treatment.